20-43515341-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001377303.1(L3MBTL1):c.703C>T(p.Leu235Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000021 in 1,429,966 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000021 ( 0 hom. )
Consequence
L3MBTL1
NM_001377303.1 missense
NM_001377303.1 missense
Scores
1
9
9
Clinical Significance
Conservation
PhyloP100: 2.22
Genes affected
L3MBTL1 (HGNC:15905): (L3MBTL histone methyl-lysine binding protein 1) This gene represents a polycomb group gene. The encoded protein functions to regulate gene activity, likely via chromatin modification. The encoded protein may also be necessary for mitosis. Alternatively spliced transcript variants encoding different isoforms have been identified.[provided by RefSeq, Sep 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3338337).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
L3MBTL1 | NM_001377303.1 | c.703C>T | p.Leu235Phe | missense_variant | 6/22 | ENST00000418998.7 | NP_001364232.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
L3MBTL1 | ENST00000418998.7 | c.703C>T | p.Leu235Phe | missense_variant | 6/22 | 2 | NM_001377303.1 | ENSP00000398516.2 | ||
ENSG00000288000 | ENST00000657241.1 | c.1384C>T | p.Leu462Phe | missense_variant | 10/26 | ENSP00000499734.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome AF: 0.00000210 AC: 3AN: 1429966Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 708520
GnomAD4 exome
AF:
AC:
3
AN:
1429966
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
708520
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2021 | The c.637C>T (p.L213F) alteration is located in exon 6 (coding exon 5) of the L3MBTL1 gene. This alteration results from a C to T substitution at nucleotide position 637, causing the leucine (L) at amino acid position 213 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;.;.;.;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
D
LIST_S2
Benign
D;D;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
.;.;.;M;M;.
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N;.;.;N;N
REVEL
Uncertain
Sift
Benign
.;T;.;.;D;D
Sift4G
Benign
.;T;.;.;T;T
Polyphen
0.96
.;.;.;.;D;.
Vest4
0.20, 0.21, 0.21
MutPred
0.21
.;.;.;Gain of methylation at K146 (P = 0.0307);Gain of methylation at K146 (P = 0.0307);Gain of methylation at K146 (P = 0.0307);
MVP
MPC
0.66
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at